Search

everythinglearnresearchcommunity

for

Search:↓

FGF9 from certain T cells helps create new hair follicles during wound healing, which could potentially be used for hair loss treatments.

The assay quickly identifies substances that increase or decrease blood vessel growth.

Sulfated fucans promote hair growth in mice by speeding up the growth phase and delaying the rest phase.

Lack of Fgf21 slows hair growth by affecting gene interactions.

Agarose/fucoidan hydrogels may help treat diabetes by supporting pancreatic cell growth.

2′‐Fucosyllactose reduces hair loss and promotes hair growth in mice.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Combining FCS and MPG is more effective for treating stable vitiligo than using either alone.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

A substance called FGF9 from certain immune cells can trigger new hair growth during wound healing in mice, but humans may not have the same response due to fewer of these cells.

Scientists made safflower seeds produce a human growth factor that could help with hair growth and wound healing.

The fer-ts mutation in plants prevents root hair growth at high temperatures.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Human growth factor 20 can boost mouse whisker growth.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Prostaglandin F2α may help treat hair loss by promoting hair growth.

WNT activation in scalp fibroblasts boosts hair growth by increasing FGF9.

The flaky skin mouse mutation is a natural model for studying human psoriasis.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

A new method using a microfluidic device can prepare hair follicle germs efficiently for potential use in hair loss treatments.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Hair glycation can indicate long-term blood sugar trends in diabetics.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.